{"ticker": {"uuid": "7630b22d-96df-483e-a77b-3861ec3a8ae6", "symbol": "1011", "name": "China NT Pharma Group Company Limited", "exchange": "HKG", "country": "HK", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "Price to book forward of China NT Pharma Group Co., Ltd. \u2013 HKEX:1011", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxQcTREMkJWMEc5VVZjMElGdHBnekhMSWZncHBuZ1o0UzJDRFEtNmxiUlZOY2xsaWZFQjg2Rzh5aDFKalphNHpUTnBVU1pJczZ1ODVEUGZIemFaQTZtUVF2X3ltYUR1aTd0RWRlQjJNMkRMLVRJVmExb09ZU0RKRGRUYjI2OHRUOTFCM1JwQzIzekZkRUdfUm5iWUZB?oc=5", "source_name": "TradingView", "published_at": "2026-07-11T00:58:11+00:00", "published_display": "11 Jul 2026 00:58", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "China NT Pharma Delays Shareholder Circular on Loan Capitalisation", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxQR2VxQUx0QW04WGlIS0VQN0xXNGZzdzhRSHZFZnNtdE11a2hUOGlSSUlqQ1JZOTVwMGtwZ1Y2cWdzUml2akNnQXVFcldITkZVTzlkVXdXMV9UVmRfdlh5Mk1JelpEMnBLVEZXcGhPdXZQVEdnaFg3c183TjUxYTlUSXR3VDFZcWdiQWp4SWRCcGNwUFMyQmZqNWROR0w2WHlUazZnT2hhczJCdzdiLWtsbHRrSzFZU2dLYUE?oc=5", "source_name": "TipRanks", "published_at": "2026-07-10T09:17:09+00:00", "published_display": "10 Jul 2026 09:17", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "China NT Pharma Proposes New Auditor CCTH CPA After Moore\u2019s Retirement", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxPYlozeVU2d3doZDlibkZPazlGdnM5bDd0UFN0cE8zWDd5RjJRQUhiOC1oQ2ZqUThuM1JtMy05aTFWSmRrVDVMVV9ISDVhRlhXcHV5M1hKT0dyeHRqN19CVE1OVFZiQnluS0ZWbm1aeXV3aENfa2Zrazl0NHNyNC1Bek1sMnNVRlhXNFpON3ZZd2l3MkdLdm13U2NKUGxiMGJiU3lJcGprbFcxcVJjdjc0bnh5dVZzTzd5dUNaS1JB?oc=5", "source_name": "TipRanks", "published_at": "2026-07-07T11:12:58+00:00", "published_display": "07 Jul 2026 11:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "China NT Pharma Tightens Controls After Review Flags Gaps in Connected Transactions", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0AFBVV95cUxNemNXd0oxVVFiWC0wWjdiaFRJaXlwYTJIRi00eHljOG9fQlN2UEwtWnV4SS1SOXBOeHZ6NEV4eDd6UnIzTTZNSTVndUtad1VhekFIZWNfeWIwTGlIeWwtSUV4LUJCNzRsQ2FWenhFZHB5RnRYc0I5WjlwdGtNdHJvZXc3TTRUci1SYlRNeTMydzRNV3hZd1N1bVhDQkdnMkJPWlM4dUNRY1pFeGZaeDlyOWJwalNtcjBua1FpR3JLMS1pOTZWRnRrQ09vQVJGTjVO?oc=5", "source_name": "TipRanks", "published_at": "2026-07-03T15:09:05+00:00", "published_display": "03 Jul 2026 15:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pharma deal could prove among sector\u2019s biggest consolidations yet", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "South China Morning Post", "published_at": "2018-05-17T07:00:00+00:00", "published_display": "17 May 2018 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NT Pharma Announces 2015 Annual Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxOQlNCbWV6aUFkQ1RnU1FZaGZvTHhhbTUyUkUxdTNRTDZsOWtvbHhJTmFFWXlJeG53eFJFbTlYQkl3MG5xX0psbDdxUjR3WkhKeHF0U2F1RjI2WUxTV0V4MjRIQm1DSTg1ZkVFX2I2clAyQlE5S080Z0RTSEdyTFZCYzJfNUdGWjZKMm1TaHowejE1TW8zNXc?oc=5", "source_name": "ACN Newswire", "published_at": "2016-03-23T07:00:00+00:00", "published_display": "23 Mar 2016 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why This China Drug Play Must Be in Your Portfolio", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxNNjFhemtQay05V2tIc1NpS0NHWHZ2OHJaUGRuZXJycjNnVTBoV0g4Smw2LWpNRG03aFpDaldTRXpRWGJSLTcyS1RTc3NUUHlLOUNBR19MOXhzRVZ3QTdualNGX3JLZEVnM3FoY0t6UWREbm5yTm9XRnRiT0NUS3pITnBybGZKTkJvSnduU3BaTDE1THU2cnFKT1hPdUY?oc=5", "source_name": "Barron's", "published_at": "2015-09-24T07:00:00+00:00", "published_display": "24 Sep 2015 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Price to book forward of China NT Pharma Group Co., Ltd. \u2013 HKEX:1011", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxQcTREMkJWMEc5VVZjMElGdHBnekhMSWZncHBuZ1o0UzJDRFEtNmxiUlZOY2xsaWZFQjg2Rzh5aDFKalphNHpUTnBVU1pJczZ1ODVEUGZIemFaQTZtUVF2X3ltYUR1aTd0RWRlQjJNMkRMLVRJVmExb09ZU0RKRGRUYjI2OHRUOTFCM1JwQzIzekZkRUdfUm5iWUZB?oc=5", "source_name": "TradingView", "published_at": "2026-07-11T00:58:11+00:00", "published_display": "11 Jul 2026 00:58", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "China NT Pharma Delays Shareholder Circular on Loan Capitalisation", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxQR2VxQUx0QW04WGlIS0VQN0xXNGZzdzhRSHZFZnNtdE11a2hUOGlSSUlqQ1JZOTVwMGtwZ1Y2cWdzUml2akNnQXVFcldITkZVTzlkVXdXMV9UVmRfdlh5Mk1JelpEMnBLVEZXcGhPdXZQVEdnaFg3c183TjUxYTlUSXR3VDFZcWdiQWp4SWRCcGNwUFMyQmZqNWROR0w2WHlUazZnT2hhczJCdzdiLWtsbHRrSzFZU2dLYUE?oc=5", "source_name": "TipRanks", "published_at": "2026-07-10T09:17:09+00:00", "published_display": "10 Jul 2026 09:17", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "China NT Pharma Proposes New Auditor CCTH CPA After Moore\u2019s Retirement", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxPYlozeVU2d3doZDlibkZPazlGdnM5bDd0UFN0cE8zWDd5RjJRQUhiOC1oQ2ZqUThuM1JtMy05aTFWSmRrVDVMVV9ISDVhRlhXcHV5M1hKT0dyeHRqN19CVE1OVFZiQnluS0ZWbm1aeXV3aENfa2Zrazl0NHNyNC1Bek1sMnNVRlhXNFpON3ZZd2l3MkdLdm13U2NKUGxiMGJiU3lJcGprbFcxcVJjdjc0bnh5dVZzTzd5dUNaS1JB?oc=5", "source_name": "TipRanks", "published_at": "2026-07-07T11:12:58+00:00", "published_display": "07 Jul 2026 11:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "China NT Pharma Tightens Controls After Review Flags Gaps in Connected Transactions", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0AFBVV95cUxNemNXd0oxVVFiWC0wWjdiaFRJaXlwYTJIRi00eHljOG9fQlN2UEwtWnV4SS1SOXBOeHZ6NEV4eDd6UnIzTTZNSTVndUtad1VhekFIZWNfeWIwTGlIeWwtSUV4LUJCNzRsQ2FWenhFZHB5RnRYc0I5WjlwdGtNdHJvZXc3TTRUci1SYlRNeTMydzRNV3hZd1N1bVhDQkdnMkJPWlM4dUNRY1pFeGZaeDlyOWJwalNtcjBua1FpR3JLMS1pOTZWRnRrQ09vQVJGTjVO?oc=5", "source_name": "TipRanks", "published_at": "2026-07-03T15:09:05+00:00", "published_display": "03 Jul 2026 15:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pharma deal could prove among sector\u2019s biggest consolidations yet", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "South China Morning Post", "published_at": "2018-05-17T07:00:00+00:00", "published_display": "17 May 2018 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NT Pharma Announces 2015 Annual Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxOQlNCbWV6aUFkQ1RnU1FZaGZvTHhhbTUyUkUxdTNRTDZsOWtvbHhJTmFFWXlJeG53eFJFbTlYQkl3MG5xX0psbDdxUjR3WkhKeHF0U2F1RjI2WUxTV0V4MjRIQm1DSTg1ZkVFX2I2clAyQlE5S080Z0RTSEdyTFZCYzJfNUdGWjZKMm1TaHowejE1TW8zNXc?oc=5", "source_name": "ACN Newswire", "published_at": "2016-03-23T07:00:00+00:00", "published_display": "23 Mar 2016 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why This China Drug Play Must Be in Your Portfolio", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxNNjFhemtQay05V2tIc1NpS0NHWHZ2OHJaUGRuZXJycjNnVTBoV0g4Smw2LWpNRG03aFpDaldTRXpRWGJSLTcyS1RTc3NUUHlLOUNBR19MOXhzRVZ3QTdualNGX3JLZEVnM3FoY0t6UWREbm5yTm9XRnRiT0NUS3pITnBybGZKTkJvSnduU3BaTDE1THU2cnFKT1hPdUY?oc=5", "source_name": "Barron's", "published_at": "2015-09-24T07:00:00+00:00", "published_display": "24 Sep 2015 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 63, "total_relevant": 7, "sentiment_summary": {"positive": 0, "negative": 0, "neutral": 7, "score": 50, "total": 7, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 78, "events": [{"event": "general", "label": "Market update", "weight": 3.1, "count": 5}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}, {"event": "earnings", "label": "Earnings", "weight": 0.55, "count": 1}], "positive_events": 0, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 0.42, "latest_week": "2026-07-10", "one_week_move": 0.0, "four_week_move": -7.7, "twelve_week_move": -38.2, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -2.020635, "market_dynamics_buy_signal": false, "relative_strength": -40.286795, "fair_value_gap": 12.4, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "negative", "expectation_probability": 31.2536, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "+0.0% over one week, -7.7% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 47, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "TipRanks", "count": 3}, {"label": "TradingView", "count": 1}, {"label": "South China Morning Post", "count": 1}, {"label": "ACN Newswire", "count": 1}, {"label": "Barron's", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 7}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 5}, {"label": "Deals and strategy", "count": 1}, {"label": "Earnings", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "78/100 classification confidence."}, {"label": "Company focus", "value": "7", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+0.0% over one week, -7.7% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Price to book forward of China NT Pharma Group Co., Ltd. \u2013 HKEX:1011"}], "updated_at": "2026-07-18T06:43:19.829126+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}